Testosterone therapy decreases subcutaneous fat and adiponectin in aging men

European Journal of Endocrinology

Volumn 166, Issue 3, 2012, Pages 469-476

  Frederiksen, L ^a,b   Hojlund K ^a,b   Hougaard, D M ^c   Mosbech, T H ^d   Larsen, R ^d   Flyvbjerg, A ^e,f   Frystyk, J ^e,f   Brixen, K ^a,b   Andersen, M ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

^d TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^e AARHUS UNIVERSITY   (Denmark)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; INSULIN; PLACEBO; TESTOSTERONE;

ABDOMINAL SUBCUTANEOUS FAT; ADULT; AGED; AGING; ANDROGEN THERAPY; ARTICLE; BODY FAT DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; DUAL ENERGY X RAY ABSORPTIOMETRY; HUMAN; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; MALE; MEN'S HEALTH; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS FAT; THERAPY EFFECT; TREATMENT DURATION; WAIST CIRCUMFERENCE;

ADIPONECTIN; AGED; AGING; BODY COMPOSITION; DOUBLE-BLIND METHOD; DOWN-REGULATION; FLUOROIMMUNOASSAY; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; MIDDLE AGED; SUBCUTANEOUS FAT; TESTOSTERONE;

EID: 84857933573     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0565     Document Type: Article

References (45)

1. O'Connell MD, Tajar A, Roberts SA & Wu FC. Do androgens play any role in the physical frailty of ageing men? International Journal of Andrology 2010 34 195-211. (doi:10.1111/j.1365-2605.2010.01093.x)
2. Frederiksen L, Hojlund K, Hougaard DM, Brixen K & Andersen M. Testosterone therapy increased muscle mass and lipid oxidation in aging men. Age, 2012. In Press. (doi:10.1007/s11357-011-9213-9)
3. Manolopoulos KN, Karpe F & Frayn KN. Gluteofemoral body fat as a determinant of metabolic health. International Journal of Obesity 2010 34 949-959. (doi:10.1038/ijo.2009.286)
4. Frederiksen L, Nielsen TL, Wraae K, Hagen C, Frystyk J, Flyvbjerg A, Brixen K & Andersen M. Subcutaneous rather than visceral adipose tissue is associated with adiponectin levels and insulin resistance in young men. Journal of Clinical Endocrinology and Metabolism 2009 94 4010-4015. (doi:10.1210/jc. 2009-0980)
5. Xu A, Chan KW, Hoo RL, Wang Y, Tan KC, Zhang J, Chen B, Lam MC, Tse C, Cooper GJ & Lam KS. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. Journal of Biological Chemistry 2005 280 18073-18080. (doi:10.1074/jbc.M414231200)
6. Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR, Aleman A, Lock TM, Bosch JL, Grobbee DE & van der Schouw YT. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. Journal of the American Medical Association 2008 299 39-52. (doi:10.1001/jama.2007.51)
7. Marin P, Holmang S, Jonsson L, Sjostrom L, Kvist H, Holm G, Lindstedt G & Bjorntorp P. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. International Journal of Obesity and Related Metabolic Disorders 1992 16 991-997. (Pubitemid 23010023)
8. Schroeder ET, Zheng L, Ong MD, Martinez C, Flores C, Stewart Y, Azen C & Sattler FR. Effects of androgen therapy on adipose tissue and metabolism in older men. Journal of Clinical Endocrinology and Metabolism 2004 89 4863-4872. (doi:10.1210/jc.2004-0784)
9. Munzer T, Harman SM, Hees P, Shapiro E, Christmas C, Bellantoni MF, Stevens TE, O'Connor KG, Pabst KM, St Clair C, Sorkin JD & Blackman MR. Effects of GH and/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men. Journal of Clinical Endocrinology and Metabolism 2001 86 3604-3610. (doi:10.1210/jc.86.8.3604)
10. Svartberg J, Agledahl I, Figenschau Y, Sildnes T, Waterloo K &Jorde R. Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip. International Journal of Impotence Research 2008 20 378-387. (doi:10.1038/ijir.2008.19)
11. Marin P, Holmang S, Gustafsson C, Jonsson L, Kvist H, Elander A, Eldh J, Sjostrom L, Holm G & Bjorntorp P. Androgen treatment of abdominally obese men. Obesity Research 1993 1 245-251.
12. Kapoor D, Clarke S, Stanworth R, Channer KS & Jones TH. The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes. European Journal of Endocrinology 2007 156 595-602. (doi:10.1530/EJE-06-0737)
13. Page ST, Herbst KL, Amory JK, Coviello AD, Anawalt BD, Matsumoto AM & Bremner WJ. Testosterone administration suppresses adiponectin levels in men. Journal of Andrology 2005 26 85-92. (Pubitemid 39665280)
14. Page ST, Amory JK, Bowman FD, Anawalt BD, Matsumoto AM, Bremner WJ & Tenover JL. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. Journal of Clinical Endocrinology and Metabolism 2005 90 1502-1510. (doi:10.1210/jc.2004-1933)
15. Nielsen TL, Hagen C, Wraae K, Brixen K, Petersen PH, Haug E, Larsen R & Andersen M. Visceral and subcutaneous adipose tissue assessed by magnetic resonance imaging in relation to circulating androgens, sex hormone-binding globulin, and luteinizing hormone in young men. Journal of Clinical Endocrinology and Metabolism 2007 92 2696-2705. (doi:10.1210/jc.2006-1847)
16. Mosbech TM, Larsen R & Vaag A. Automatic segmentation of abdominal adipose tissue in MRI. Lecture Notes in Computer Science, Proceedings of the 17th Scandinavian Conference on Image Analysis 1-1-2011.
17. Vermeulen A, Verdonck L & Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. Journal of Clinical Endocrinology and Metabolism 1999 84 3666-3672. (doi:10.1210/jc.84.10.3666)
18. Frystyk J, Tarnow L, Hansen TK, Parving HH & Flyvbjerg A. Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications. Diabetologia 2005 48 1911-1918. (doi:10.1007/s00125-005-1850-z)
19. Hother-Nielsen O, Henriksen JE, Holst JJ & Beck-Nielsen H. Effects of insulin on glucose turnover rates in vivo: isotope dilution versus constant specific activity technique. Metabolism 1996 45 82-91. (doi:10.1016/S0026- 0495(96)90204-8)
20. Vickers AJ & Altman DG. Statistics notes: analysing controlled trials with baseline and follow up measurements. BMJ 2001 323 1123-1124. (doi:10.1136/bmj.323.7321.1123)
21. Altman DG. Clinical trials. In Practical Statistics for Medical Research, pp 440-478. London: Chapmann and Hall, 1999.
22. Wang C, Catlin DH, Demers LM, Starcevic B & Swerdloff RS. Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. Journal of Clinical Endocrinology and Metabolism 2004 89 534-543. (doi:10.1210/jc.2003- 031287)
23. Isidori AM, Giannetta E, Greco EA, Gianfrilli D, Bonifacio V, Isidori A, Lenzi A & Fabbri A. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clinical Endocrinology 2005 63 280-293. (doi:10.1111/j.1365-2265.2005.02339.x)
24. Allan CA, Strauss BJ, Burger HG, Forbes EA & McLachlan RI. Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men. Journal of Clinical Endocrinology and Metabolism 2008 93 139-146. (doi:10.1210/jc.2007-1291)
25. Mhatre AN, Trifiro MA, Kaufman M, Kazemi-Esfarjani P, Figlewicz D, Rouleau G & Pinsky L. Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nature Genetics 1993 5 184-188. (doi:10.1038/ng1093-184)
26. Tut TG, Ghadessy FJ, Trifiro MA, Pinsky L & Yong EL. Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. Journal of Clinical Endocrinology and Metabolism 1997 82 3777-3782. (doi:10.1210/jc.82.11. 3777)
27. Nielsen TL, Hagen C, Wraae K, Bathum L, Larsen R, Brixen K &Andersen M. The impact of the CAG repeat polymorphism of the androgen receptor gene on muscle and adipose tissues in 20-29-year-old Danish men: Odense Androgen Study. European Journal of Endocrinology 2010 162 795-804. (doi:10.1530/EJE-09-0763)
28. Swarbrick MM & Havel PJ. Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metabolic Syndrome and Related Disorders 2008 6 87-102. (doi:10.1089/met.2007. 0029)
29. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K & Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. Journal of Clinical Investigation 2006 116 1784-1792. (doi:10.1172/JCI29126)
30. Fain JN, Madan AK, Hiler ML, Cheema P & Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004 145 2273-2282. (doi:10.1210/en.2003-1336)
31. Fujikawa R, Ito C, Nakashima R, Orita Y & Ohashi N. Is there any association between subcutaneous adipose tissue area and plasma total and high molecular weight adiponectin levels? Metabolism 2008 57 506-510. (doi:10.1016/j.metabol.2007.11.012)
32. Lanfranco F, Zitzmann M, Simoni M & Nieschlag E. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy. Clinical Endocrinology 2004 60 500-507. (doi:10.1111/j.1365-2265.2004.02007.x)
33. Xu X, De PG & Bjorntorp P. The effects of androgens on the regulation of lipolysis in adipose precursor cells. Endocrinology 1990 126 1229-1234. (doi:10.1210/endo-126-2-1229)
34. Rebuffe-Scrive M, Marin P & Bjorntorp P. Effect of testosterone on abdominal adipose tissue in men. International Journal of Obesity 1991 15 791-795.
35. Plaisance EP, Grandjean PW, Judd RL, Jones KW & Taylor JK. The influence of sex, body composition, and nonesterified fatty acids on serum adipokine concentrations. Metabolism 2009 58 1557-1563. (doi:10.1016/j.metabol. 2009.04.038)
36. Fasshauer M, Klein J, Neumann S, Eszlinger M & Paschke R. Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Letters 2001 507 142-146. (doi:10.1016/S0014- 5793(01)02960-X)
37. Wang Y, Lam KS, Yau MH & Xu A. Post-translational modifications of adiponectin: mechanisms and functional implications. Biochemical Journal 2008 409 623-633. (doi:10.1042/BJ20071492)
38. AndersenKK, Frystyk J,WolthersOD,HeuckC&FlyvbjergA.Gender differences of oligomers and total adiponectin during puberty: a cross-sectional study of 859 Danish school children. Journal of Clinical Endocrinology and Metabolism 2007 92 1857-1862. (doi:10.1210/jc.2006-2310)
39. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB &Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Medicine 2002 8 1288-1295. (doi:10.1038/nm788)
40. Whitsel EA, Boyko EJ, Matsumoto AM, Anawalt BD &Siscovick DS. Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis. American Journal of Medicine 2001 111 261-269. (doi:10.1016/S0002-9343(01)00833-6)
41. Fernandez-Balsells MM, Murad MH, Lane M, Lampropulos JF, Albuquerque F, Mullan RJ, Agrwal N, Elamin MB, Gallegos- Orozco JF, Wang AT, Erwin PJ, Bhasin S & Montori VM. Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism 2010 95 2560-2575. (doi:10.1210/jc.2009-2575)
42. Jones TH, Arver S, Behre HM, Buvat J, Meuleman E, Moncada I, Morales AM, Volterrani M, Yellowlees A, Howell JD & Channer KS. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 Study). Diabetes Care 2011 34 828-837. (doi:10.2337/dc10-1233)
43. Kalinchenko SY, Tishova YA, Mskhalaya GJ, Gooren LJ, Giltay EJ &Saad F. Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study. Clinical Endocrinology 2010 73 602-612. (doi:10.1111/j.1365-2265.2010.03845.x)
44. Nair KS, Rizza RA, O'Brien P, Dhatariya K, Short KR, Nehra A, Vittone JL, Klee GG, Basu A, Basu R, Cobelli C, Toffolo G, Dalla MC, Tindall DJ, Melton LJ III, Smith GE, Khosla S & Jensen MD. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 2006 355 1647-1659. (Pubitemid 44583955)
45. Kapoor D, Goodwin E, Channer KS & Jones TH. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 2006 154 899-906. (Pubitemid 43997730)